Cargando…
Myostatin inhibition therapy for insulin-deficient type 1 diabetes
While Type 1 Diabetes Mellitus (T1DM) is characterized by hypoinsulinemia and hyperglycemia, persons with T1DM also develop insulin resistance. Recent studies have demonstrated that insulin resistance in T1DM is a primary mediator of the micro and macrovascular complications that invariably develop...
Autores principales: | Coleman, Samantha K., Rebalka, Irena A., D’Souza, Donna M., Deodhare, Namita, Desjardins, Eric M., Hawke, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007491/ https://www.ncbi.nlm.nih.gov/pubmed/27581061 http://dx.doi.org/10.1038/srep32495 |
Ejemplares similares
-
Inhibition of myostatin signaling increases glucose in insulin-deficient diabetic mice
por: Wang, Qian, et al.
Publicado: (2012) -
Impaired Macrophage and Satellite Cell Infiltration Occurs in a Muscle-Specific Fashion Following Injury in Diabetic Skeletal Muscle
por: Krause, Matthew P., et al.
Publicado: (2013) -
Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin‐Deficient Diabetic Mice
por: Bunn, R Clay, et al.
Publicado: (2023) -
Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice
por: Rebalka, Irena A., et al.
Publicado: (2017) -
Muscle and serum myostatin expression in type 1 diabetes
por: Dial, Athan G., et al.
Publicado: (2020)